European Drugmakers' Shares Hold Firm Amid Trump's 100% Tariff Threat

Trump's New Pharmaceutical Tariffs

• 🇺🇸 US President Donald Trump announced sweeping new import tariffs, including 100% levies on branded drugs, set to take effect on October 1st.
• ❓ It remains unclear if these new levies will be in addition to existing national tariffs.

Existing Trade Agreements and Potential Limits

• 🤝 Recent trade deals with Japan, the EU, and Britain contain provisions that cap tariffs for pharmaceuticals.
• 🇪🇺 A preliminary trade deal between the EU and US agreed to limit levies to 15%, though Trump has not yet signed an executive order confirming this.

Drugmakers' Investments and Market Reaction

• 💰 Bracing for potential tariffs, drugmakers like Switzerland's Roche and Novartis have announced multi-billion dollar investments in the US.
• 🎯 The president stated the 100% drug levies would only apply to producers who have failed to establish a presence in the country.
• 📈 After initial losses, pharmaceutical stocks recovered as markets awaited further details on the tariff implementation.